Ilaris (canakinumab)

pCPA File Number: 21028

Negotiation Status:

Concluded with an LOI

Indication(s):

Systemic juvenile idiopathic arthritis

Sponsor/Manufacturer:

Novartis Pharmaceuticals Canada Inc.

CDA-AMC Project Number:

Not Applicable

pCPA Engagement Letter Issued:

2018-04-27

Negotiation Process Concluded:

2018-11-19